Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could gentle fascia release restore shoulder mobility after breast cancer surgery?

NCT ID NCT05386628

Symptom relief Sponsor: Istanbul Medeniyet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether myofascial chain release techniques—gentle manual therapy targeting the connective tissue around muscles—can improve shoulder range of motion in women who have had a mastectomy for breast cancer. Participants will receive either standard physiotherapy or physiotherapy plus myofascial release. The study measures shoulder flexibility, tissue stiffness, pain, and daily function to see if this approach offers added benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
myofascial chain release techniques
What this could lead to
If effective, this approach could offer a non-drug way to improve shoulder movement and daily function for breast cancer survivors after mastectomy.
What could go wrong
This is a small early-stage trial, so results may not apply broadly. The technique's benefit over standard physiotherapy is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Aug 2022

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women between the ages of 30-60 * Having breast surgery within 2 years * Not have received conservative treatment for shoulder rehabilitation in the last 6 months * Having limitation of movement of the shoulder joint due to breast surgery Exclusion Criteria: * Not having agreed to participate in the study * Having undergone radical mastectomy surgery * Having connective tissue disease * Presence of brachial plexus paresis/plegia * Presence of radiogenic fibrosis * Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions * Presence of active metastases * Having undergone reconstruction surgery * Continuation of radiotherapy (must have ended at least 3 months ago) or chemotherapy applications * Having had a bilateral mastectomy * To develop lymphedema in the arm-trunk * Use of muscle relaxants * Patients with severe chemotherapy side effects (hyperesthesia, nausea, skin changes, weakness, etc.)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer survivors

Contacts and locations

Locations

  • İstanbul Medeniyet University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.